Trial Search Results
Use of New Supraglottic Airway Devices in Severely Obese Patients: A Feasibility Study
The purpose of this study is to determine whether two new airway devices used during anesthesia called iGEL™ and KING-LTS-DTM work well and are safe in obese patients. They both work well in thin patients, but have not been tested in obese patients.
Stanford is currently not accepting patients for this trial.
University of Louisville
- Device: IGEL
- Device: King airway
- Scheduled for elective surgery with an estimated duration of 30 to 120 minutes
- American Society of Anesthesiologists (ASA) status I-III
- Aged 18 to 65 years.
- Body mass index (BMI) ≥ 35 kg/m2
- A history of difficult intubation;
- Immobilized cervical spine;
- Oxygen saturation less than 95% at room air;
- A history of uncontrolled gastroesophageal reflux or hiatus hernia;
- A history of ulcer surgery including vagotomy;
- Previous gastric bypass surgery;
- Diabetic gastroparesis;
- Patients with known coagulation disorders (e.g. hemophilias, von Willebrand disease,
factor V leiden diseases) or on systemic anticoagulation drugs (e.g. continuous
heparin infusion); Patients with abnormal coagulation tests will be also excluded.
However, asymptomatic patients will not be tested on any coagulation disorders.
- Any pathologies of the mouth, pharynx or larynx, the access to the airway is
restricted, or a difficult tracheal intubation is anticipated.
- Pregnant or breast-feeding (pregnancy status will be confirmed by a pregnancy test, as
it is standard for all surgical procedures at the University hospital).
Ages Eligible for Study
18 Years - 65 Years
Genders Eligible for Study